Skip to content

Reconstructions With Back Donor Site Flaps and Validation of Quality of Life Scales

Reconstructions With Back Donor Site Flaps and Validation of Quality of Life Scales

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04526561
Enrollment
550
Registered
2020-08-26
Start date
2020-08-01
Completion date
2024-12-31
Last updated
2025-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

The latissimus dorsi flap is the oldest and most used technique for breast reconstruction. Nonetheless, there are few studies evaluation the long-term effect of harvesting one of the muscles of the back. This project has four parts. 1. Validation of scales/instrument for Swedish. 2. Long-term results after reconstruction with latissimus dorsi- a ten year retrospective follow-up. 3. Thoracodorsal artery perforator flap (TDAP) vs latissimus dorsi flap- a randomized controlled trial - breast reconstruction. 4. TDAP vs Limber flap - a randomized controlled trial- reconstruction of axillary hidradenitis suppurativa.

Interventions

Breast reconstruction

PROCEDUREThoracodorsal artery perforator flap to breast

Breast reconstruction

Breast reconstruction

Sponsors

Vastra Gotaland Region
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients eligible for breast reconstruction following mastectomy and radiation * Non-smokers or ex-smokers (\>6 weeks) * BMI \< 30

Exclusion criteria

* Inability to leave informed consent * Inability to understand Swedish * Previous surgery with scaring on back

Design outcomes

Primary

MeasureTime frameDescription
Patient satisfaction and breast-related quality of life after breast reconstruction10 yearsBreast Q reconstruction.The BREAST-Q has multiple domains, each scored from 0 to 100 (higher scores indicate greater satisfaction or quality of life), there is no overall BREAST-Q score.
Abdominal satisfaction after breast reconstruction10 yearsBreast Q abdominal satisfaction and abdominal well-being.The scale is scored from 0 (worst) to 100
Shoulder function after breast reconstruction10 yearsWestern Ontario Osteoarthritis of the shoulder index (WOOS) provides scores on four domains: (1) physical symptoms; (2) sport, recreation, and work; (3) lifestyle; and (4) emotions.Each question has a possible score from 0-100 giving a total score up to 1900. The highest or most symptomatic score is 1900 and the best or asymptomatic score is 0.
Back appearance after breast reconstruction10 yearsBreast-Q the back appearance scale.The scale is scored from 0 (worst) to 100 (best). Higher scores reflect a better outcome.
Back and shoulder function after breast reconstruction10 yearsBreast Q the back and shoulder function scale. The scale is scored from 0 (worst) to 100 (best). Higher scores reflect a better outcome.

Secondary

MeasureTime frameDescription
Complications after breast reconstruction2 yearsMeasured in patients randomized to TDAP or latissimus dorsi flap.

Other

MeasureTime frameDescription
Validation of Breast Q: The Back Appearance scale for Swedish1 yearTranslation and validation of the instrument for Swedish
Normal material for Breast-Q back and shoulder function scale5 yearsMeasurement of quality of life according to breast-Q back and shoulder function scale in a normative population
Normal material for Breast-Q back appearance scale5 yearsMeasurement of quality of life according to breast-Q back appaearance scale in a normative population
Normal material for Breast-Q5 yearsMeasurement of quality of life according to breast-Q in a normative population
Validation of Breast-Q: The back and shoulder function scale for Swedish1 yearTranslation and validation of the instrument for Swedish

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026